Follicular Lymphoma

Conference Coverage

Targeted agent shows early promise for NHL

follicular lymphoma LUGANO—An anti-CD37 antibody-radionuclide conjugate provides sustained efficacy and a manageable safety profile in patients...

Conference Coverage

EZH2 inhibitor proves active in rel/ref NHL

LUGANO—The EZH2 inhibitor tazemetostat (EPZ-6438) has shown “meaningful clinical activity” as monotherapy in patients with advanced non-Hodgkin...